GSA Capital Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,873
| Closed | -$452K | – | 1744 |
|
|
2025
Q1 | $452K | Buy |
+3,873
| New | +$452K | 0.04% | 868 |
|
|
2022
Q4 | – | Sell |
-10,916
| Closed | -$487K | – | 1458 |
|
|
2022
Q3 | $487K | Buy |
+10,916
| New | +$487K | 0.06% | 583 |
|
|
2022
Q2 | – | Sell |
-18,656
| Closed | -$772K | – | 1399 |
|
|
2022
Q1 | $772K | Buy |
18,656
+10,699
| +134% | +$443K | 0.1% | 292 |
|
|
2021
Q4 | $301K | Buy |
+7,957
| New | +$301K | 0.04% | 926 |
|
|
2021
Q3 | – | Sell |
-9,366
| Closed | -$632K | – | 1414 |
|
|
2021
Q2 | $632K | Buy |
+9,366
| New | +$632K | 0.07% | 483 |
|